Nirva Medical

Saint Paul, United States Founded: 2010 • Age: 16 yrs
Developer of a device to treat heart attack

About Nirva Medical

Nirva Medical is a Healthcare company based in Saint Paul (United States) founded in 2010 by Pramote Hochareon. Developer of a device to treat heart attack. Nirva Medical has raised $260 thousand across 1 funding round. Nirva Medical offers products and services including Catheter Technology. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is NirvaMed Inc. Its competitors include Precise Bio, TherOx and Nininger Medical; 2 of its 3 listed competitors have raised funding.

Company details

Nirva Medical has developed a device for treating heart attacks. The device is used to apply cold temperatures using its localized heart cooling technology to the heart muscles. The company claims that the device is used to prevent heart muscle tissue damage or death that is caused by reperfusion injuries, before or after angioplasty procedures to avoid heart attacks.

  • Headquarters Saint Paul, United States
  • Founders Pramote Hochareon
  • Sectors
    Healthcare
  • Website nirvamedical.com
  • Social LinkedIn
  • Legal Name Nirvamed Inc.
Key Metrics
  • Total Equity Funding
    $260K (USD)

    in 1 rounds

  • Latest Funding Round
    $260K (USD), Seed

    Apr 2015

Products & Services of Nirva Medical

Nirva Medical offers a comprehensive portfolio of products and services, including Catheter Technology.

Catheter Technology
Medical Device

Advanced catheter for treating heart conditions like STEMI.

Funding Insights of Nirva Medical

Nirva Medical has successfully raised a total of $260K through 1 strategic funding round. The most recent funding activity was a Seed round of $260 thousand completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $260,000
  • Total Rounds 1
  • Last Round Seed β€” $260,000
  • First Round $260,000

    (Apr 2015)

All 1 funding rounds of Nirva Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2015$260,000Seed––
–

People of Nirva Medical

1 people are tracked at Nirva Medical (1 in leadership).

NameRoleGroup
Pramote Hochareon
FounderLeadership
Premium access

Complete people profiles for Nirva Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nirva Medical

2 dated milestones of Nirva Medical across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nirva Medical is founded.
  2. Funding First funding round of $260K.

Competitors of Nirva Medical

Nirva Medical has 3 listed competitors in our database, 2 of them funded. They include Precise Bio, TherOx and Nininger Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
precise-bio.com2015Winston-salem, United States$12M6
Developer of integrated 3D printing and tissue-engineering platform
therox.com1995Irvine, United States$113.44M17
Super saturated oxygen therapy for reducing cardiac muscle damage
niningermed.com2019Brea, United States
Technological solutions for structural heart failure patients are developed.
Premium access

Detailed competitors of Nirva Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Nirva Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nirva Medical

Nirva Medical was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Nirva Medical is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.

Nirva Medical is a funded company, having raised a total of $260K across 1 funding round to date. The company's 1st funding round was a Seed of $260K, raised on Apr 2015.

Nirva Medical has developed a device for treating heart attacks. The device is used to apply cold temperatures using its localized heart cooling technology to the heart muscles. The company claims that the device is used to prevent heart muscle tissue damage or death that is caused by reperfusion injuries, before or after angioplasty procedures to avoid heart attacks.

Nirva Medical's top competitors include Precise Bio, TherOx and Nininger Medical.

Nirva Medical offers Catheter Technology.

Nirva Medical operates through Nirvamed Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available